From: Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis
 | Maternal use of psychiatric drugs |  | |||
---|---|---|---|---|---|
Ref. | First author, year | Exposure | ORcrude [95% CI] | ORadj [95% CI] | Adjustment/matching factors |
[52] | Furu, 2015 | Any SSRI | 1.5 [0.95, 2.37] | 1.4 [0.88, 2.32] | Maternal age, year of birth, birth order, smoking, maternal diabetes, and country, and use of other prescribed drugs (antiepileptics, anxiolytics and hypnotics, and angiotensin converting enzyme inhibitors) |
Sertraline | 2.8 [1.33, 5.92] | 2.5 [1.09, 5.57] | |||
Citalopram | 1.6 [0.70, 3.48] | 1.5 [0.64, 3.25] | |||
[50] | Wemakor, 2015 | Any SSRI | – | 2.5 [1.06, 5.68] | Registry |
Fluoxetine | – | 2.6 [0.60, 10.91] | |||
Paroxetine | – | 2.8 [0.66, 11.96] | |||
Citalopram | – | 2.2 [0.29, 16.63] | |||
Sertraline | – | – | |||
Escitalopram | – | 6.0 [0.73, 49.62] | |||
[76] | Källén, 2013 | Opioids | – | – | – |
Anticonvulsants | 2.9 [0.96, 6.86]a | – |  | ||
Neurolepticsb | – | – |  | ||
Dixyrazine or prochlorperazine | – | – |  | ||
Sedatives or hypnotics | 1.2 [0.33, 3.06]a | – |  | ||
Antidepressants | 1.2 [0.66, 2.10] | – |  | ||
[54] | Polen, 2013 | Antidepressantsc | – | – | – |
Venlafaxinec | – | – |  | ||
[56] | Reis and Källén, 2010 | Antidepressants | 1.1 [0.40, 2.36]a | – | – |
[68] | Alwan, 2007 | Any SSRI | 1.0 [0.4, 2.0] | 0.7 [0.3, 1.8] | Maternal race or ethnic group, presence or absence of maternal obesity, presence or absence of maternal smoking, and family income |
[64] | Louik, 2007 | Any SSRI | – | 1.9 [0.8, 4.3] | Maternal age, maternal race or ethnic group (self-reported), maternal education, year of last menstrual period/study center (a composite variable), parity, first-trimester smoking status, first-trimester alcohol consumption, any family history of a birth defect, history of a cardiac defect in a first-degree relative, prepregnancy body-mass index, seizures, diabetes mellitus, hypertension, infertility, any use of folic acid, and first-trimester use of folic acid |
Fluoxetine | – | 1.4 [0.3, 6.1] | |||
Paroxetine | – | 1.0 [0.1, 7.8] | |||
Citalopram | – | 3.0 [0.3, 28.2] | |||
Sertraline | – | 4.4 [1.2, 16.4] | |||
Non-SSRI antidepressant | – | 2.2 [0.6, 7.8] | |||
[65] | Czeizel, 2003 | Diazepam in entire pregnancy Diazepam in second-third months of gestation | 2.2 [1.2, 3.9] | 1.9 [1.1, 3.3] | – |
10.0 [1.3, 78.1] | 5.2 [1.4, 19.7] | Â | |||
[43] | Bonnot, 2001 | Lorazepam | – | 6.2 [2.44, 15.74] | Maternal age and parity |